SPRO
SPRO
NASDAQ · Biotechnology

Spero Therapeutics Inc

$1.19
-0.04 (-3.25%)
As of Sep 28, 10:20 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +2,533.6% upside
Low Target $21.51
Average Target $31.34
High Target $48.77
Current Price $1.19
Current
$1.19
Target
$31.34
$21.51 $31.34 avg $48.77
Scenario Analysis
Bear Case
$21.51
1,707.6%
Low target
Base Case
$31.34
+2,533.6%
Avg target
Bull Case
$48.77
+3,998.3%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.08
-61.4% from high
52-Week Low
$1.08
+10.2% from low
Target vs 52W High
$31.34
+917.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%